Gershon / Lerer | New Directions in Affective Disorders | Buch | 978-1-4612-8140-5 | sack.de

Buch, Englisch, 732 Seiten, Format (B × H): 155 mm x 235 mm, Gewicht: 1153 g

Gershon / Lerer

New Directions in Affective Disorders


Softcover Nachdruck of the original 1. Auflage 1989
ISBN: 978-1-4612-8140-5
Verlag: Springer

Buch, Englisch, 732 Seiten, Format (B × H): 155 mm x 235 mm, Gewicht: 1153 g

ISBN: 978-1-4612-8140-5
Verlag: Springer


This book is presented as a 1989 update on the task set by Robert Burton in his "Anatomy ofMelancholy," published in 1621. Burton's treatise addressed ques­ tions regarding depression which are still highly relevant today: ". What is it, with all the kinds, causes, symptoms, prognostickes and several cures ofit. " These remain the core issues in affective disorders notwithstanding the remarkable progress that has been made in addressing them. New Directions in Affective Disorders sets out to provide an overviewofwhat has been achieved with particular emphasison developing trends and novel initiatives in bothfundamental research and treatment. The overriding objective of the book is to integrate significant contributions from basic and clinical science into a comprehensive format which will be of value to both clinicians and researchers. Intensive interest in affective illness isan inevitableconsequenceofthe frequency with which these disorders occur. Depression is the most common psychiatric condition, affecting as many as 50%ofpeople in Western countries at some time in their lives. National Institute ofMental Health Statistics estimate that 15% of adults between 18 and 74 years ofage may be suffering from serious depressive disorders in any given year. Depression is a serious condition with a high mortality. A suicide rate ofapproximately 20,000 deaths per year as a result of this illness is almost certainly a conservative estimate.

Gershon / Lerer New Directions in Affective Disorders jetzt bestellen!

Zielgruppe


Research

Weitere Infos & Material


Contributors.- I Pathogenesis of Affective Disorders and Basic Mechanisms of Drug Action.- I.A. Animal Models and Antidepressant Predictability.- I.B. Monoamines and Neuropeptides.- I.C. Cholinergic Mechanisms.- I.D. Basic Mechanisms of Antidepressants and Anxiolytics.- I.E. Basic Mechanisms of Lithium Action.- I.F. Monoamine Oxidase Inhibitors.- II Neurobiology of Affective Disorders.- II. A. New Genetic Findings.- II.B. Biological Markers.- II.C. Chronobiology.- II.D. Psychoneuroendocrinology.- III Affective Disorders in Populations at Risk.- III.A. Affective Disorders and Suicide.- III.B. Affective Disorders During Childhood and Adolescence.- III.C. Affective Disorders in the Elderly.- III.D. Affective Disorders and Reproductive Cyclicity in Women.- IV Related Affective Syndromes.- IV.A. Anxiety Disorders.- IV.B. Obsessive Compulsive Disorder.- IV.C. Posttraumatic Stress Disorder.- IV.D. Anorexia and Bulimia.- IV.E. Schizoaffective Disorder.- V New Directions in Treatment.- V.A. Classification and Pharmacotherapy.- V.B. Anticonvulsants in Affective Disorder.- V.C. Treatment Strategies for Resistant Depression.- V.D. Antidepressants in Clinical Practice: Placebo Response in Depression.- V.D. Antidepressants in Clinical Practice: Plasma Levels of Antidepressants.- V.D. Antidepressants in Clinical Practice: Adverse Effects of Antidepressants.- V.E. GABA-Mimetics as Antidpressants.- V.F. Therapeutic Variations in ECT Administration.- V.G. Psychotherapy of Depression.



Ihre Fragen, Wünsche oder Anmerkungen
Vorname*
Nachname*
Ihre E-Mail-Adresse*
Kundennr.
Ihre Nachricht*
Lediglich mit * gekennzeichnete Felder sind Pflichtfelder.
Wenn Sie die im Kontaktformular eingegebenen Daten durch Klick auf den nachfolgenden Button übersenden, erklären Sie sich damit einverstanden, dass wir Ihr Angaben für die Beantwortung Ihrer Anfrage verwenden. Selbstverständlich werden Ihre Daten vertraulich behandelt und nicht an Dritte weitergegeben. Sie können der Verwendung Ihrer Daten jederzeit widersprechen. Das Datenhandling bei Sack Fachmedien erklären wir Ihnen in unserer Datenschutzerklärung.